Bahram Valamehr

ORCID

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Venues

Nature communications

Science translational medicine

Blood

This page only lists publications with an associated author ORCID identifier.

Publications

Frank Cichocki, Jodie P Goodridge, Ryan Bjordahl, Sajid Mahmood, Zachary B Davis, Svetlana Gaidarova, Ramzey Abujarour, Brian Groff, Alec Drake Witty, Hongbo Wang, Katie Tuininga, Behiye Kodal, Martin Felices, Gregory B Bonello, Janel Huffman, Thomas Dailey, Tom T Lee, Bruce Walcheck, Bahram Valamehr, Jeffrey S Miller
Dual-antigen targeted off-the-shelf NK cells show durable response and prevent antigen escape in lymphoma and leukemia. Blood (2022)
Frank Cichocki, Ryan Bjordahl, Jodie P Goodridge, Sajid Mahmood, Svetlana Gaidarova, Ramzey Abujarour, Zachary B Davis, Aimee M Merino, Katie Tuininga, Hongbo Wang, Akhilesh Kumar, Brian Groff, Alec Witty, Greg Bonello, Janel Huffman, Thomas Dailey, Tom T Lee, Karl-Johan Malmberg, Bruce Walcheck, Uta E Höpken, Armin Rehm, Bahram Valamehr, Jeffrey S Miller
Quadruple gene-engineered natural killer cells enable multi-antigen targeting for durable antitumor activity against multiple myeloma. Nature communications 13 (1) (2022)
Frank Cichocki, Ryan Bjordahl, Svetlana Gaidarova, Sajid Mahmood, Ramzey Abujarour, Hongbo Wang, Katie Tuininga, Martin Felices, Zachary B Davis, Laura Bendzick, Raedun Clarke, Laurel Stokely, Paul Rogers, Moyar Ge, Megan Robinson, Betsy Rezner, David L Robbins, Tom T Lee, Dan S Kaufman, Bruce R Blazar, Bahram Valamehr, Jeffrey S Miller
iPSC-derived NK cells maintain high cytotoxicity and enhance in vivo tumor control in concert with T cells and anti-PD-1 therapy. Science translational medicine 12 (568) (2021)

Bahram Valamehr.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Bahram Valamehr